Back to Search
Start Over
Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study
- Source :
- Haematologica, Haematologica, Ferrata Storti Foundation, 2020, ⟨10.3324/haematol.2019.224535⟩
- Publication Year :
- 2020
- Publisher :
- Ferrata Storti Foundation (Haematologica), 2020.
-
Abstract
- International audience
- Subjects :
- Oncology
medicine.medical_specialty
[SDV]Life Sciences [q-bio]
Treatment outcome
Phases of clinical research
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Text mining
Internal medicine
medicine
In patient
Letters to the Editor
Abemaciclib
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
0303 health sciences
Mantle cell lymphoma
business.industry
non-Hodgkin lymphoma
[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology
Hematology
medicine.disease
3. Good health
Lymphoma
Clinical trial
chemistry
030220 oncology & carcinogenesis
Refractory Mantle Cell Lymphoma
CDK4 and 6 inhibitor
business
Subjects
Details
- ISSN :
- 15928721 and 03906078
- Volume :
- 106
- Database :
- OpenAIRE
- Journal :
- Haematologica
- Accession number :
- edsair.doi.dedup.....29c7d227d503893449b11894361ddc8a
- Full Text :
- https://doi.org/10.3324/haematol.2019.224535